Zions Bancorporation, N.A. Gilead Sciences, Inc. Transaction History

Zions Bancorporation, N.A.

$1.36 Billion
Q3 2024

A detailed history of Zions Bancorporation, N.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 115,611 shares of GILD stock, worth $10.7 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

115,611

Previous 108,280 6.77%

Holding current value

$10.7 Million

Previous $7.43 Million 30.43%

% of portfolio

0.71%

Previous 0.6%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$66.59 - $83.99 $488,171 - $615,730	7,331 Added 6.77%	115,611 $9.69 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $929,189 - $1.07 Million	14,714 Added 15.73%	108,280 $7.43 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $3.1 Million - $3.78 Million	43,358 Added 86.36%	93,566 $6.85 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $125,145 - $141,917	1,708 Added 3.52%	50,208 $4.07 Million
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $666,347 - $726,998	9,012 Added 22.82%	48,500 $3.63 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $1.9 Million - $2.17 Million	-24,991 Reduced 38.76%	39,488 $3.04 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $3.31 Million - $3.77 Million	-42,774 Reduced 39.88%	64,479 $5.35 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $676,109 - $970,660	-10,849 Reduced 9.19%	107,253 $9.21 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $550,506 - $628,820	9,246 Added 8.49%	118,102 $7.29 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $1.5 Million - $1.69 Million	26,067 Added 31.49%	108,856 $6.73 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.49 Million - $1.86 Million	25,677 Added 44.96%	82,789 $4.92 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $238,433 - $270,627	3,675 Added 6.88%	57,112 $4.15 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $250,046 - $269,772	3,694 Added 7.43%	53,437 $3.73 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $279,648 - $305,556	4,406 Added 9.72%	49,743 $3.43 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $364,620 - $416,031	6,077 Added 15.48%	45,337 $2.93 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $353,326 - $402,598	6,237 Added 18.89%	39,260 $2.29 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $1.24 Million - $1.56 Million	20,029 Added 154.14%	33,023 $2.09 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $1.4 Million - $1.63 Million	-19,417 Reduced 59.91%	12,994 $1 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $462,835 - $592,825	7,390 Added 29.54%	32,411 $2.42 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $126,690 - $139,355	-2,056 Reduced 7.59%	25,021 $1.63 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $1.53 Million - $1.69 Million	24,474 Added 940.22%	27,077 $1.72 Million
Q2 2019 Jul 09, 2019	SELL	$61.87 - $69.38 $2,536 - $2,844	-41 Reduced 1.55%	2,603 $176,000
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $165,329 - $185,212	2,644 New	2,644 $172,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Gilead Sciences, Inc. Transaction History